Paediatric Respiratory Reviews

Papers
(The TQCC of Paediatric Respiratory Reviews is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation143
COVID-19 and telehealth, education, and research adaptations124
Vaccines for COVID-19: The current state of play90
Challenges of COVID-19 in children in low- and middle-income countries79
Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes48
Role of modelling in COVID-19 policy development43
Thromboinflammation in COVID-19 acute lung injury40
Vaccines for COVID-19: Where do we stand in 2021?32
An update on controversies in e-cigarettes28
European and United Kingdom COVID-19 pandemic experience: The same but different27
COVID-19: A tale of two pandemics across the Asia Pacific region26
Oxidative stress and obesity-related asthma24
Consequences of physical distancing emanating from the COVID-19 pandemic: An Australian perspective21
Modelling insights into the COVID-19 pandemic20
CFTR modulator therapies – Effect on life expectancy in people with cystic fibrosis17
Covid-19 and the impact on young athletes16
Impact of early life exposures on respiratory disease16
Restoration of exocrine pancreatic function in older children with cystic fibrosis on ivacaftor15
Real-world respiratory and bulbar comorbidities of SMA type 1 children treated with nusinersen: 2-Year single centre Australian experience15
Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology15
What we have learnt about trauma, loss and grief for children in response to COVID-1914
Ultrasound assessment of ventilator-induced diaphragmatic dysfunction in mechanically ventilated pediatric patients13
Pediatric pulmonary lymphatic flow Disorders: Diagnosis and management12
Cystic fibrosis in low and middle-income countries (LMIC): A view from four different regions of the world12
Covid-19 in children: A brief overview after three months experience12
Hyperinflammation and the utility of immunomodulatory medications in children with COVID-1911
COVID-19 and respiratory support devices11
Social robots and therapeutic adherence: A new challenge in pediatric asthma?11
Developmental Origins of Health and Disease (DOHaD): The importance of life-course and transgenerational approaches11
Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects10
Initiating home spirometry for children during the COVID-19 pandemic – A practical guide10
Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?10
Weaning oxygen in infants with bronchopulmonary dysplasia10
High-flow nasal cannula in children with asthma exacerbation: A review of current evidence8
Covid-19 in pregnant women and babies: What pediatricians need to know8
Health disparities in pediatric sleep-disordered breathing8
Abnormal pulmonary lymphatic flow in patients with paediatric pulmonary lymphatic disorders: Diagnosis and treatment7
Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses7
Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis7
Tuberculosis in pregnant women and neonates: A meta-review of current evidence7
Does machine learning have a role in the prediction of asthma in children?7
Paediatric obesity-related asthma: Disease burden and effects on pulmonary physiology7
Chronic sleep deprivation in teenagers: Practical ways to help7
Saline nasal irrigation for acute upper respiratory tract infections in infants and children: A systematic review and meta-analysis6
Chest imaging in paediatric pulmonary TB6
Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children?6
Preventing tuberculosis in children: A global health emergency6
Pediatric lung function testing during a pandemic: An international perspective6
Economic burden of childhood asthma in children attending a follow-up clinic in a resource-poor setting of Southeast Nigeria6
Lung ultrasound in children: What does it give us?6
Contribution of systemic and airway immune responses to pediatric obesity-related asthma5
Systematic review of clinical practice guidelines on the management of community acquired pneumonia in children5
Cystic fibrosis related diabetes (CFRD) in the era of modulators: A scoping review5
Journey towards a personalised medicine approach for OSA: Can a similar approach to adult OSA be applied to paediatric OSA?5
Electronic cigarettes and e-cigarette/vaping product use associated lung injury (EVALI)4
Cardiovascular issues in obstructive sleep apnoea in children: A brief review4
Weight loss in obese children with asthma – is it important?4
Investigation of neutrophil/lymphocyte ratio and mean platelet volume in patients diagnosed with preterm labor4
Bronchoscopy precautions and recommendations in the COVID-19 pandemic4
Early environmental exposures and life-long risk of chronic non-respiratory disease4
The role of cardiopulmonary exercise testing in evaluating children with exercise induced dyspnoea4
A scoping review of mHealth monitoring of pediatric bronchial asthma before and during COVID-19 pandemic4
Long-term non-invasive ventilation in children: Transition from hospital to home4
Responses of three urban U.S. Children’s Hospitals to COVID-19: Seattle, New York and New Orleans4
Tuberculosis treatment in children: The changing landscape4
0.027338027954102